Citadel Advisors’s Innovator US Equity Accelerated 9 Buffer ETF April XBAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-22,360
Closed -$646K 15378
2023
Q3
$646K Buy
22,360
+13,788
+161% +$402K ﹤0.01% 7504
2023
Q2
$248K Buy
+8,572
New +$240K ﹤0.01% 9420
2022
Q1
Sell
-27,833
Closed -$764K 14714
2021
Q4
$764K Buy
27,833
+9,723
+54% +$264K ﹤0.01% 8602
2021
Q3
$480K Sell
18,110
-391,475
-96% -$10.4M ﹤0.01% 9973
2021
Q2
$10.8M Buy
+409,585
New +$10.7M ﹤0.01% 2957

Other funds holding XBAP

Citadel Advisors's XBAP Position: Q4 2023 in Review

Citadel Advisors sold out of Innovator US Equity Accelerated 9 Buffer ETF April (XBAP) in Q4 2023, closing a stake of 22,360 shares — an estimated $646K sold.

Citadel Advisors first reported a position in XBAP in Q2 2021 and held it in 5 quarters. The position peaked at $10.8M in Q2 2021. 35 funds tracked by Wall St. Rank hold XBAP as of Q4 2023.

  • Citadel Advisors reported no remaining Innovator US Equity Accelerated 9 Buffer ETF April position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 22,360 Innovator US Equity Accelerated 9 Buffer ETF April shares in Q4 2023, an estimated $646K.
  • Citadel Advisors first reported a position in Innovator US Equity Accelerated 9 Buffer ETF April in Q2 2021 and held it in 5 quarters.
  • Citadel Advisors's Innovator US Equity Accelerated 9 Buffer ETF April position peaked at $10.8M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Innovator US Equity Accelerated 9 Buffer ETF April as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.